DrugPatentWatch Database Preview
Ge Healthcare Company Profile
What is the competitive landscape for GE HEALTHCARE, and when can generic versions of GE HEALTHCARE drugs launch?
GE HEALTHCARE has fifty-four approved drugs.
There are seven US patents protecting GE HEALTHCARE drugs.
Summary for Ge Healthcare
| US Patents: | 7 |
| Tradenames: | 62 |
| Ingredients: | 42 |
| NDAs: | 54 |
| Drug Master File Entries: | 5 |
| Patent Litigation for Ge Healthcare: | See patent lawsuits for Ge Healthcare |
Drugs and US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ge Healthcare | TECHNETIUM TC 99M MPI MDP | technetium tc-99m medronate kit | INJECTABLE;INJECTION | 018141-002 | Jun 12, 1989 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Ge Healthcare | HYPAQUE SODIUM 20% | diatrizoate sodium | SOLUTION;URETERAL | 009561-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Ge Healthcare | HYPAQUE-76 | diatrizoate meglumine; diatrizoate sodium | INJECTABLE;INJECTION | 086505-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Ge Healthcare
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Ge Healthcare | OMNIPAQUE 70 | iohexol | SOLUTION;URETHRAL | 018956-007 | Jun 1, 1994 | 4,250,113 | ➤ Try a Free Trial |
| Ge Healthcare | VISIPAQUE 320 | iodixanol | INJECTABLE;INJECTION | 020808-002 | Aug 29, 1997 | 5,349,085 | ➤ Try a Free Trial |
| Ge Healthcare | OMNIPAQUE 300 | iohexol | SOLUTION;INJECTION, ORAL, RECTAL | 018956-003 | Dec 26, 1985 | 4,250,113 | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for Ge Healthcare Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 9305819 | ➤ Try a Free Trial |
| Canada | 2694084 | ➤ Try a Free Trial |
| Japan | 2006522104 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Ge Healthcare Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 90009-5 | Sweden | ➤ Try a Free Trial | PRODUCT NAME: FLUTEMETAMOL (18F); REG. NO/DATE: EU/1/14/941 20140826 |
| 00673 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: PACLITAXEL, GEFORMULEERD ALS ALBUMINE-GEBONDEN NANODEELTJES; REGISTRATION NO/DATE: EU/1/07/428/001-002 20131220 |
| 0689 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN ATORVASTATINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER ATORVASTATINE CALCIUM TRIHYDRATE; NATIONAL REGISTRATION NO/DATE: RVG114373-114376 20141027; FIRST REGISTRATION: FR 2014091200122 20140912 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
